BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8609900)

  • 21. CB1 cannabinoid receptor-mediated cell migration.
    Song ZH; Zhong M
    J Pharmacol Exp Ther; 2000 Jul; 294(1):204-9. PubMed ID: 10871313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
    Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine modulates voltage-gated Ca2+ channels in adult rat sympathetic neurons.
    Zhu Y; Ikeda SR
    J Neurophysiol; 1993 Aug; 70(2):610-20. PubMed ID: 8410161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
    Mackie K; Hille B
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3825-9. PubMed ID: 1315042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.
    Fan P
    J Neurophysiol; 1995 Feb; 73(2):907-10. PubMed ID: 7760148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M2 muscarinic receptor-mediated inhibition of the Ca2+ current in rat magnocellular cholinergic basal forebrain neurones.
    Allen TG; Brown DA
    J Physiol; 1993 Jul; 466():173-89. PubMed ID: 8410690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons.
    Shen M; Thayer SA
    Brain Res; 1998 Feb; 783(1):77-84. PubMed ID: 9479052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurosteroids modulate calcium currents in hippocampal CA1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism.
    ffrench-Mullen JM; Danks P; Spence KT
    J Neurosci; 1994 Apr; 14(4):1963-77. PubMed ID: 8158251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
    Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
    Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.
    Vásquez C; Navarro-Polanco RA; Huerta M; Trujillo X; Andrade F; Trujillo-Hernández B; Hernández L
    Can J Physiol Pharmacol; 2003 May; 81(5):436-42. PubMed ID: 12774849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P2Y2 nucleotide receptors expressed heterologously in sympathetic neurons inhibit both N-type Ca2+ and M-type K+ currents.
    Filippov AK; Webb TE; Barnard EA; Brown DA
    J Neurosci; 1998 Jul; 18(14):5170-9. PubMed ID: 9651200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of calcium currents by a metabotropic glutamate receptor involves fast and slow kinetic components in cultured hippocampal neurons.
    Sahara Y; Westbrook GL
    J Neurosci; 1993 Jul; 13(7):3041-50. PubMed ID: 8392538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cannabinoids on synaptic transmission in the frog neuromuscular junction.
    Sánchez-Pastor E; Trujillo X; Huerta M; Andrade F
    J Pharmacol Exp Ther; 2007 May; 321(2):439-45. PubMed ID: 17267583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
    McIntosh BT; Hudson B; Yegorova S; Jollimore CA; Kelly ME
    Br J Pharmacol; 2007 Dec; 152(7):1111-20. PubMed ID: 17922024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds.
    Sugiura T; Kodaka T; Nakane S; Miyashita T; Kondo S; Suhara Y; Takayama H; Waku K; Seki C; Baba N; Ishima Y
    J Biol Chem; 1999 Jan; 274(5):2794-801. PubMed ID: 9915812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
    Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
    Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH; Oriowo MA
    Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.